A targeted complement will cure what ails you
Main Category: Immune System / VaccinesArticle Date: 27 Aug 2005 - 4:00 PDT
| Patient / Public: | ![]() | |
| Healthcare Prof: | ![]() |
The pathogenesis of many inflammatory, autoimmune and ischemic diseases are due to inappropriate activation of the complement system - proteins found in blood that help destroy bacteria and other foreign cells. Complement inhibitors are now used therapeutically but there are unresolved questions regarding their clinical use. Complement activation products are important for host defense and regulation of the immune system, and thus complement inhibition may compromise this protection.
In a study appearing online on August 25 in advance of print publication of the September 1 issue of the Journal of Clinical Investigation, Stephen Tomlinson and colleagues from the Medical University of South Carolina show that appropriate targeting of complement inhibition to sites of complement activation and disease can improve bioavailability and increase efficacy without systemically inhibiting complement. They do this by using mouse models of intestinal ischemia/reperfusion (I/R) injury and of acute infection.
By not systemically inhibiting complement, complement-dependent host defense is not compromised. The targeting strategy involved a novel technique and provided protection from injury in the lung, where complement-dependent injury occurs following intestinal I/R. Currently available complement inhibitory drugs systemically inhibit complement and are not optimal. This new targeting strategy is a step forward for developing better complement inhibitors.
TITLE:Targeted complement inhibition by C3d recognition ameliorates tissue injury without apparent increase in susceptibility to infection
AUTHOR:
Stephen Tomlinson
Medical University of South Carolina, Charleston, SC USA
View the PDF of this article at:
the-jci.org/article.php?id=25208
Stacie Bloom
press_releases@the-jci.org
212-342-4159
Journal of Clinical Investigation
http://www.jci.org
Visit our immune system / vaccines section for the latest news on this subject.
MLA
15 Feb. 2012. <http://www.medicalnewstoday.com/releases/29742.php>
APA
http://www.medicalnewstoday.com/releases/29742.php.
Please note: If no author information is provided, the source is cited instead.
|
Rate this article: (Hover over the stars then click to rate) |
Patient / Public: |
or |
Health Professional: |
Add Your Opinion
Please note that we publish your name, but we do not publish your email address. It is only used to let you know when your message is published. We do not use it for any other purpose. Please see our privacy policy for more information.
If you write about specific medications or operations, please do not name health care professionals by name.
All opinions are moderated before being included (to stop spam)
Contact Our News Editors
For any corrections of factual information, or to contact the editors please use our feedback form.
![]()
Please send any medical news or health news press releases to:
Note: Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our terms and conditions.



